Located at the Sir YK Pao Centre for Cancer of the Prince of Wales Hospital, the State Key Laboratory in Oncology in South China is backed by a strong clinical base, made possible by the long-standing support of the Hospital Authority and the Food and Health Bureau of the Hong Kong SAR Government. Of special significance, this strategic location has prompted the readiness for research outputs to be translated into clinical solutions that bring hope and benefits to the patients. The Comprehensive Cancer Trials Unit in the Sir YK Pao Centre for Cancer is also accredited as the only centre in Hong Kong that can conduct clinical trials in oncology for the Chinese State Food and Drug Administration (SFDA).

The SKL serves as an important platform for extending its scientific achievements to benefit the wider Chinese community and anchors its role in spearheading international collaborations in medical research as well as promoting scientific development of the nation. The investigators of the State Key Laboratory in Oncology in South China are a multidisciplinary group of clinical and basic cancer researchers within the Chinese University of Hong Kong and Sun Yat-sen University. In the past two years, we have conducted intensive research investigating the molecular genetics, signaling pathways, clinical diagnostics and novel therapeutic developments of cancers that are common to our region, in particular nasopharyngeal cancer, liver cancer and gastric cancer.